Pirh2、p53的相互关系及其在恶性肿瘤中的作用
被引量:1
出处
《医学临床研究》
CAS
2007年第7期1214-1217,共4页
Journal of Clinical Research
基金
湖南省卫生厅科研基金课题资助(编号B2005-021)
参考文献24
-
1Roger P.Leng,Yunping Lin,Weili Ma,et al.Pirh2,a p53induced ubiquitin-protein ligase,promotes p53 degradation[J].Cell,2003;112(6):779-791.
-
2Logan IR,Sapountzi V,Gaughan L,et al.Control of human PIRH2 protein stability:involvement of TIP60 and the proteosome[J].J Biol Chem,2004,279(12):11696-11704.
-
3L.K.Beitel,Y.A.Elhaji,R.Lumbroso,et al.Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity[J].J Mol Endocrinol,2002;29(1):41-60.
-
4Batsakis JG,EL-Naggar AK.P53:fifteen years after discovery[J].Advan Anat Pathol,1995;2:71.
-
5Halevy O.Different tumor-derived P53 mutants exhibit distinct biological activities[J].Science,1990;250:113.
-
6Marchetti P,Cannita K,Ricevuto E,et al.Prognostic value of P53 molecular status in high risk primary breast cancer[J].Ann Oncol,2003,14(5):704-708.
-
7Sangrajran S,Arpornwirat W,Cheirsilpa A,et al.Serum p53 antibodies incorrelation to other biologieal parameters of breast cancer[J].Cancer Detect Prev,2003,27(3):182-186.
-
8Linjawi A,Kontogiannea M,Halwani F,et al.Prognostic significance of p53,bcl-2,and Bax expression in early breast cancer[J].J Am Coll Surg,2004,198(1):83-90.
-
9Duan W,Oao L,Druhan LJ,et al.Expression of Pirh2,a newly identified ubiquitin protein ligase,in lung cancer[J].J Natl Cancer Inst,2004,96(22):1718-1721.
-
10Harris SL,Levine Aj.The P53 pathway:positive and negative feedback loops[J].Oacogene,2005,18,24(17):2899.
二级参考文献7
-
1Tao W, Levine AJ. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc Natl Acad Sci USA, 1999,96:3077-3080.
-
2Yu ZK, Geyer RK, Maki CG. MDM2-dependent ubiquitination of nuclear and cytoplasmic p53. Oncogene,2000,119:5892-5897.
-
3Xirodimas DP, Stephen CW, Lane DP. Cocompartmentalization of p53 and MDM2 is a major determinant for MDM2-mediated degradation of p53. Exp Cell Res,2001,270:66-77.
-
4Zhang Y, Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science,2001,292:1910.
-
5Liang S-H, Clarke MF. A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem, 1999,274: 32699-32703.
-
6Stommel JM, Marchenko ND, Jimene GS, et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J, 1999,18: 1660- 1672.
-
7Blattner C, Hay T, Meek DW, et al. Hypophosphorylation of MDM2 augments p53 stability. Mol Cell Biol, 2002,22:6170-6182.
共引文献7
-
1张鸿瑞,何春年.鼠双微体基因2与p53在子宫颈癌发生中的作用[J].中国医疗前沿,2008,3(16):5-6.
-
2巴艳华,李惠平.鼠双微粒体2/p53通路与乳腺癌的研究进展[J].北京大学学报(医学版),2006,38(5):551-554.
-
3艾耀伟,于红刚,于皆平,杨艳,李欢,胡晓雯,罗和生.P13K/Akt/mdm2信号通路活化对胃癌细胞阿霉素敏感性的影响[J].中华肿瘤杂志,2008,30(7):494-497. 被引量:10
-
4吕佳音,高忠礼,王金成,吴丹凯,赵东旭,张舵舵,赵燕颖.RNA干扰沉默mdm2治疗骨肉瘤的实验研究[J].中华肿瘤杂志,2008,30(7):502-505. 被引量:2
-
5李惠平.乳腺癌内分泌联合靶向治疗的分子基础[J].中国肿瘤,2009,18(6):474-477.
-
6田秀娟,于梦潇,秦瑞,曹璐,冷维春,刘俊宝.卵巢上皮性癌组织中MDM2蛋白的表达及其临床意义[J].吉林大学学报(医学版),2011,37(5):902-905. 被引量:1
-
7夏阳,武斌,张毅,李吉达.核定位信号及其在病毒感染机制中的研究进展[J].微生物学通报,2021,48(3):896-905. 被引量:4
同被引文献19
-
1Hainaut P, WimanKG. 30 years and a long way into p53 re- search[ J]. Lancet 0ncol,2009,10(9) :913 -919.
-
2Leng PR,Lin Y,MA W. Pirh2 ,a p53 - induced ubiqutin - protein ligase, promtes p53 degradation [ J ]. Cell, 2003,112 (6) :779 -791.
-
3Logan I R, Sapountzi V, Gaughanl, et al. Control of human PIRH2 protein stbility: involvement of Tip60 and the prote- odome[ J]. J Biol Chem,2004,279(12) :11696 - 11704.
-
4Linzer DL,Levrne AJ. Characterization of a 54K surviv cel- lular SV40 tumor antigen present in SV40 -transformed cells and uninfected embryonal carcinoma cells [ J ]. Cell, 1979,19(1) :43 -45.
-
5Vogelstein B, Lane D, Levine A. Surfing the p53 network [ J ]. Nature,2000,408 (6810) : 307 - 310.
-
6Morita N,Ikeda Y,Takami H. Clinical significance of p53 protein expression in papillary thyoid carcinoma [ J ]. World J surg,2008 ,32 :2617 - 2622.
-
7张学良,王华.甲状腺癌肿瘤标志物及相关基因研究进展[J].交通医学,2008,22(2):132-136. 被引量:4
-
8张珊文.中国p53基因治疗的现状和前景[J].医学研究杂志,2008,37(6):3-5. 被引量:13
-
9王承红.p53基因在肿瘤放疗中的研究进展[J].医学综述,2010,16(2):205-207. 被引量:19
-
10陈青,邬黎青.p53基因和乳腺癌的相关性研究进展[J].实验与检验医学,2011,29(1):57-59. 被引量:9
-
1刘俊文,杨向东.泛素-蛋白酶体途径介导的细胞周期调节蛋白的水解[J].国外医学(老年医学分册),2005,26(1):30-34. 被引量:4
-
2孙力超,林江涛.组蛋白去乙酰化酶6的研究进展[J].国际呼吸杂志,2011,31(18):1399-1402.
-
3杨学丽,路三军,魏娉,安欣,尹峰,孙健.DKK-1和β-catenin在近端胃腺癌中的表达及临床意义[J].河北医药,2014,36(21):3214-3216.
-
4Aaron Ciechanover,葛亮.泛素介导的蛋白质降解系统——从基础研究到临床应用[J].生命科学,2010,22(3):212-215. 被引量:6
-
5叶飞,高庆蕾,徐同江,雷霆.LRIG1对胶质瘤细胞中表皮生长因子受体的抑制作用及其机制[J].华中科技大学学报(医学版),2009,38(1):49-51. 被引量:4
-
6魏清,万小云.应用RNA干扰技术研究AKT和ERK2基因对子宫内膜癌细胞自噬活性的影响[J].中华妇产科杂志,2009,44(8):634-635. 被引量:1
-
7肖春花,冯玉梅,李晓青,郝希山.基质金属蛋白酶-2和纤维粘连蛋白在乳腺癌细胞系的定量表达[J].中华实验外科杂志,2005,22(5):527-529. 被引量:7
-
8赵广宁,丁娜,孙岩,韩瑞发.Vasohibin-1与肿瘤[J].国际肿瘤学杂志,2013,40(4):252-255.
-
9邢娟.细胞外泛素作用的研究[J].中国医师进修杂志,2012,35(21):75-77.
-
10邓世山.泛素-蛋白酶体系统介导的蛋白质降解在乳腺癌发病机制中的作用[J].川北医学院学报,2008,23(6):553-556. 被引量:6